Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence, they have enhanced the recovery potential of patients with neurological diseases.

Combining FDA-cleared and CE-marked digital therapeutics with best-in-class motion analytics, AI, and cloud technologies, MindMaze aims to create the universal platform for brain health.

MindMaze Labs, their R&D division, brings groundbreaking neuroscience to everyday life by harnessing the power of the brain to empower the next generation of human-machine interfaces.

MindMaze has pioneered neurorehabilitation with unique VR-based digital therapeutics and peripherals, securing multiple FDA and CE clearances and numerous patents. Their flagship products include MindMotion™ PRO and MindMotion™ GO platforms, widely adopted in leading medical institutions globally.

They have expanded operations internationally, achieved unicorn status, and formed strategic partnerships with medical centers such as Johns Hopkins and Mount Sinai. Their innovations include advanced motion analytics, AI-driven therapy, teleneurorehabilitation, and FDA-listed hyper-sensitive controllers for hand motor function impairments.